LATIN AMERICA NEWBORN SCREENING MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

LATIN AMERICA NEWBORN SCREENING MARKET 2019-2027

Market By Product, Test Type, Technology And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton's research report anticipates the Latin America newborn screening market to upsurge with a CAGR of 12.91% in the forecast period of 2019 to 2027.

The countries considered in the report on Latin America’s newborn screening market are:

•           Brazil

•           Mexico

•           Rest of Latin America

Report scope can be customized per your requirements. Request For Customization

In Mexico, the most pivotal step is that the secretary of Health and the Mexican Social Security Institute together has screened more than 70% of all newborns in the country, which is further augmenting the growth of the newborn screening market in the Latin American region. According to the Canadian PKU and Allied Disorders Association, the combined population accounts for around 600 million, with annual births that account for 11 million. The newborn screening programs that have been going on for around 20-30 years in the countries which mainly include Cuba, Costa Rica, Uruguay and Chile are constantly focusing on expanding their coverage, and in the present scenario, all these four countries have a reach to around 99% of the newborn population of the country. According to the association, Chile has expanded newborn screening to include around 25 conditions in 2015, and the researchers in Cuba have reported on launching several new screening techniques considering both traditional and future screening. In the present scenario, newborn screening in Cuba has been decentralized through more than 175 laboratories.

A rise in the global population of the world has been observed, owing to the rising fertility rate. According to the WHO, 130 million infants are born in per year, of which 2.6 million die in the first 28 days of their life. Newborn infants are more prone to infection, which can occur at any time from the first day of life. Newborn screening tests are done to diagnose the congenital or inborn abnormalities of metabolism to identify the disease in neonatal investigations. The growing fertility rate is likely to raise the demand for newborn screening market. These tests are done immediately after the birth of the baby, and are able to detect metabolic, genetic and developmental disorders in newborns.

 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. LATIN AMERICA NEWBORN SCREENING MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1. DEMAND FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY

2.2.2. GROWTH IN DRY BLOOD SPOT TEST

2.2.3. TECHNIQUES USED IN NEWBORN SCREENING TESTS

2.3. EVOLUTION & TRANSITION OF NEWBORN SCREENING

2.4. PORTER’S FIVE FORCE ANALYSIS

2.4.1. THREAT OF NEW ENTRANTS

2.4.2. THREAT OF SUBSTITUTE

2.4.3. BARGAINING POWER OF SUPPLIERS

2.4.4. BARGAINING POWER OF BUYERS

2.4.5. THREAT OF COMPETITIVE RIVALRY

2.5. KEY IMPACT ANALYSIS

2.5.1. RELIABILITY

2.5.2. COST

2.5.3. AVAILABILITY

2.5.4. TECHNOLOGICAL ADVANCEMENT

2.6. MARKET ATTRACTIVENESS INDEX

2.7. VENDOR SCORECARD

2.8. INDUSTRY COMPONENTS

2.8.1. RAW MATERIAL SUPPLIERS

2.8.2. MANUFACTURERS

2.8.3. DISTRIBUTORS

2.8.4. END-USERS

2.9. REGULATORY FRAMEWORK

2.10. INDUSTRY PLAYER POSITIONING

2.11. KEY MARKET STRATEGIES

2.11.1. PRODUCT LAUNCH

2.12. MARKET DRIVERS

2.12.1. INCREASE IN OCCURRENCES OF NEWBORN DISEASES

2.12.2. GROWING NUMBER OF INFANTS WITH BIRTH DEFECT

2.12.3. BACKING OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH

2.12.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE

2.13. MARKET RESTRAINTS

2.13.1. ABSENCE OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES

2.13.2. SOCIO-ECONOMIC HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING

2.14. MARKET OPPORTUNITIES

2.14.1. INCREASING FERTILITY RATES ACROSS THE GLOBE IS CREATING DYNAMIC GROWTH

2.14.2. NEWBORN SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS

2.14.3. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING

2.14.4. INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE

2.15. MARKET CHALLENGES

2.15.1. DEARTH OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY

2.15.2. MAINTENANCE OF EQUIPMENT IN HOSPITAL

3. NEWBORN SCREENING MARKET OUTLOOK - BY PRODUCT

3.1. NEWBORN SCREENING INSTRUMENTS

3.2. NEWBORN SCREENING REAGENTS & ASSAY KITS

4. NEWBORN SCREENING MARKET OUTLOOK - BY TEST TYPE

4.1. HEARING SCREEN TEST

4.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST

4.3. DRY BLOOD SPOT TEST

5. NEWBORN SCREENING MARKET OUTLOOK - BY TECHNOLOGY

5.1. TANDEM MASS SPECTROMETRY

5.2. PULSE OXIMETRY

5.3. ENZYME-BASED ASSAYS

5.4. DNA-BASED ASSAYS

5.5. ELECTROPHORESIS

5.6. OTHERS

6. NEWBORN SCREENING MARKET - REGIONAL OUTLOOK

6.1. BRAZIL

6.2. MEXICO

6.3. REST OF LATIN AMERICA

7. COMPETITIVE LANDSCAPE

7.1. SCIEX

7.2. BIOTEK INSTRUMENTS, INC.

7.3. BIO-RAD LABORATORIES, INC.

7.4. CARDINAL HEALTH, INC.

7.5. GE HEALTHCARE LIMITED

7.6. AGILENT TECHNOLOGIES, INC.

7.7. MASIMO CORPORATION

7.8. NATUS MEDICAL, INCORPORATED

7.9. MEDTRONIC PLC

7.10. THERMO FISHER SCIENTIFIC, INC.

7.11. NEOGEN LABS PVT. LTD.

7.12. PERKINELMER, INC.

7.13. ZENTECH S.A.

7.14. WATERS CORPORATION

7.15. TRIVITRON HEALTHCARE

8. METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1: LATIN AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS INDEX

TABLE 3: VENDOR SCORECARD

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: LIST OF PRODUCT LAUNCHES

TABLE 6: INFANT MORTALITY RATE IN DEVELOPING COUNTRIES (TOTAL DEATHS/ 1000 LIVE BIRTHS)

TABLE 7: LATIN AMERICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)

TABLE 8: LATIN AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)

TABLE 9: LATIN AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)

TABLE 10: LATIN AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

 

List of Figures

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: KEY BUYING IMPACT ANALYSIS

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: INDUSTRY PLAYER POSITIONING IN 2018 (IN %)

FIGURE 5: FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) IN 2017

FIGURE 6: LATIN AMERICA NEWBORN SCREENING MARKET, BY NEWBORN SCREENING INSTRUMENTS, 2019-2027 (IN $ MILLION)

FIGURE 7: LATIN AMERICA NEWBORN SCREENING MARKET, BY NEWBORN SCREENING REAGENTS & ASSAY KITS, 2019-2027 (IN $ MILLION)

FIGURE 8: LATIN AMERICA NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $ MILLION)

FIGURE 9: LATIN AMERICA NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST, 2019-2027 (IN $ MILLION)

FIGURE 10: LATIN AMERICA NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $ MILLION)

FIGURE 11: LATIN AMERICA NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN $ MILLION)

FIGURE 12: LATIN AMERICA NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $ MILLION)

FIGURE 13: LATIN AMERICA NEWBORN SCREENING MARKET, BY ENZYME-BASED ASSAY, 2019-2027 (IN $ MILLION)

FIGURE 14: LATIN AMERICA NEWBORN SCREENING MARKET, BY DNA-BASED ASSAYS, 2019-2027 (IN $ MILLION)

FIGURE 15: LATIN AMERICA NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $ MILLION)

FIGURE 16: LATIN AMERICA NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)

FIGURE 17: LATIN AMERICA NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

FIGURE 18: BRAZIL NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 19: MEXICO NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

FIGURE 20: REST OF LATIN AMERICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;